Antibiotice Ia Capital Reinvestment Ratio
Antibiotice Ia capital reinvestment ratio. Antibiotice Ia (ATB) has a Capital Reinvestment Ratio of 2.63x as of June 2026, meaning it reinvests 3% of its operating cash flow (RON18.71 Million) in capital expenditures (RON49.25 Million). Check how aggressively does Antibiotice Ia reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Antibiotice Ia (2022–2025)
Capital reinvestment ratio of Antibiotice Ia from 2022 to 2025. This chart tracks Antibiotice Ia's Capital Reinvestment Ratio across 4 annual periods. Also explore net asset momentum of Antibiotice Ia to track the company's year-over-year net asset growth rate.
Antibiotice Ia Capital Reinvestment Ratio by Year (2022–2025)
Antibiotice Ia capital reinvestment ratio by year from 2022 to 2025. For the full cash flow conversion analysis, see Antibiotice Ia operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (RON) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.97x | RON72.44 Million | RON142.61 Million | ▲ +61.3% |
| 2024 | 1.22x | RON95.15 Million | RON116.16 Million | ▲ +52.5% |
| 2023 | 0.80x | RON122.46 Million | RON98.04 Million | ▲ +132.2% |
| 2022 | 0.34x | RON115.66 Million | RON39.88 Million | — |